Company Filing History:
Years Active: 2010-2014
Title: Uwe Von Ahsen: Pioneering Antigen Research in Vienna
Introduction
Uwe Von Ahsen, located in Vienna, Austria, is a notable inventor with a remarkable contribution to the field of immunology. With four patents to his name, Uwe has been instrumental in advancing methods for the identification, isolation, and production of antigens for specific pathogens. His innovative approaches have the potential to significantly impact vaccine development for both animals and humans.
Latest Patents
Uwe's latest patents focus on methods for identifying and producing hyperimmune serum-reactive antigens. These methods involve several key steps, including the preparation of antibodies and screening expression libraries to identify antigens that bind to these antibodies. Notably, his patents detail processes to identify hyperimmune serum-reactive antigens, which can be isolated and produced through chemical or recombinant methods. This innovation holds great promise for vaccines targeting specific pathogens, tumors, allergens, or tissues prone to autoimmunity.
Career Highlights
Throughout his career, Uwe Von Ahsen has worked with esteemed organizations such as Intercell AG and Valneva Austria GmbH. His experience in these companies has allowed him to refine his methodologies and contribute to significant advancements in antigen research and vaccine development.
Collaborations
Uwe's work has also involved collaboration with notable colleagues, including Andreas Meinke and Eszter Nagy. These partnerships have fostered an environment of innovation, leading to breakthroughs in the field of immunology and enhancing the effectiveness of vaccine strategies.
Conclusion
In summary, Uwe Von Ahsen's contributions to the field of antigen research and vaccine development are commendable. With a strong patent portfolio and collaborative efforts with key industry professionals, Uwe continues to make significant strides in health science, positioning himself as a leader in the quest for effective immunological treatments. His innovative methods pave the way for future research and potential applications in medical science.